Investing Ideas
/
Global Pharmaceuticals & Biotech Large Cap High Growth Potential

Global Pharmaceuticals & Biotech Large Cap High Growth Potential

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

43 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ALNY Alnylam Pharmaceuticals	US$256.45	-7.1%	74.5%	US$33.2b	US$299.57	PS14.8x	E58.7%	n/a
A196170 ALTEOGEN	₩394,000.00	0.6%	334.4%	₩21.0t	₩565,000.00	PS282.3x	E140.6%	n/a
ITCI Intra-Cellular Therapies	US$127.82	0.6%	69.0%	US$13.6b	US$132.73	PS22.1x	E52.9%	n/a
SRPT Sarepta Therapeutics	US$107.95	-3.5%	-19.8%	US$10.3b	US$181.78	PE84.6x	E30.1%	n/a
NBIX Neurocrine Biosciences	US$115.02	-6.2%	-13.1%	US$11.5b	US$166.45	PE33.6x	E27.1%	n/a
A068270 Celltrion	₩180,800.00	0.7%	4.2%	₩38.4t	₩235,952.38	PE205x	E74.1%	0.4%
603392 Beijing Wantai Biological Pharmacy Enterprise	CN¥68.53	1.0%	9.2%	CN¥86.7b	CN¥61.40	PS34.8x	E109.4%	0.5%
ARGX argenx	€607.80	-3.8%	66.2%	€36.9b	€632.14	PS20.3x	E41.8%	n/a
LLY Eli Lilly	US$844.27	-3.9%	8.0%	US$760.2b	US$981.47	PE71.8x	E21.7%	0.7%
VRTX Vertex Pharmaceuticals	US$459.00	-2.2%	8.7%	US$117.9b	US$497.87	PS10.7x	E29.5%	n/a
500420 Torrent Pharmaceuticals	₹3,011.50	-7.6%	14.0%	₹1.0t	₹3,639.83	PE54.7x	E23.3%	0.9%
SDZ Sandoz Group	CHF 44.57	1.1%	55.2%	CHF 19.6b	CHF 45.08	PS2.1x	E29.5%	1.0%
AZN AstraZeneca	UK£117.08	0.9%	16.0%	UK£181.5b	UK£140.78	PE32.5x	E16.6%	2.1%
ILMN Illumina	US$100.24	-9.7%	-30.1%	US$15.9b	US$147.56	PS3.6x	E56.7%	3.1%
GALD Galderma Group	CHF 112.54	-2.7%	n/a	CHF 26.7b	CHF 107.26	PS6.9x	E36.6%	n/a
ABBV AbbVie	US$192.87	1.2%	8.7%	US$340.5b	US$204.90	PE80.3x	E25.3%	3.4%
DIM Sartorius Stedim Biotech	€211.00	-0.2%	-16.9%	€20.5b	€240.00	PE127.8x	E32.4%	0.3%
UCB UCB	€180.45	-4.6%	90.1%	€34.2b	€202.88	PE142.6x	E28.4%	0.8%
DIVISLAB Divi's Laboratories	₹5,843.75	-4.8%	56.7%	₹1.6t	₹5,774.85	PE75.1x	E22.3%	0.5%
BMY Bristol-Myers Squibb	US$53.90	-5.2%	8.1%	US$109.4b	US$61.24	PS2.3x	E34.4%	4.6%
TECH Bio-Techne	US$65.94	-9.4%	-7.9%	US$10.4b	US$86.96	PE65.9x	E21.9%	0.5%
INCY Incyte	US$70.42	-5.0%	21.5%	US$13.6b	US$78.26	PE417.8x	E23.8%	n/a
ONC BeiGene	US$230.86	3.3%	55.7%	US$24.6b	US$284.05	PS7.6x	E66.6%	n/a
LONN Lonza Group	CHF 595.40	-1.4%	30.3%	CHF 43.0b	CHF 659.86	PE67.6x	E21.1%	0.7%

Page 1 of 2